[1] |
Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children[J]. Arerugi,1967,16(3):178-222.
|
[2] |
Li D, Chen X, Li X, et al. Effectiveness and safety of dual antiplatelet therapy in coronary aneurysms caused by Kawasaki disease in children: study protocol for a multicenter randomized clinical trial[J]. Transl Pediatr,2021,10(7):1914-1923.
|
[3] |
张新艳, 杨婷婷, 何婷, 等. 2012至2016年单中心川崎病流行病学及临床特征研究[J]. 中国循证儿科杂志,2018,13(6):427-433.
|
[4] |
朱妍洁, 黄国英. 川崎病诊断中的生物标志物[J]. 国际儿科学杂志,2019,46(2):77-80.
|
[5] |
赵峥山, 黄国英. 川崎病冠状动脉病变的遗传学研究进展[J]. 国际儿科学杂志,2018,45(5):329-332.
|
[6] |
崔青, 沈捷. 川崎病冠状动脉病变的手术治疗[J]. 中华实用儿科临床杂志,2021,36(10):789-793.
|
[7] |
Singh S, Gupta A, Jindal A, et al. Pulmonary presentation of Kawasaki disease-A diagnostic challenge[J]. Pediatr Pulmonol,2018,53(1):103-107.
|
[8] |
Colomba C, La Placa S, Saporito L, et al. Intestinal involvement in kawasaki disease[J]. J Pediatr,2018,202:186-193.
|
[9] |
Seerat I, Khan EUD, Atique M, et al. Clinical spectrum of chronic liver disease with final outcome in children at a tertiary centre: A single-centre study[J]. Pak J Med Sci,2021,37(3):680-683.
|
[10] |
董琛, 黄志华. 婴儿胆汁淤积性肝病的诊断及鉴别诊断[J]. 中华实用儿科临床杂志,2018,33(19):1441-1447.
|
[11] |
Zafar M, Farooq M, Butler-Manuel W, et al. Vanishing bile duct syndrome associated with non-hodgkin’s lymphoma and hepatitis E virus infection[J]. Cureus,14(1):e21328.
|
[12] |
Ji SB, Lee SS, Jung HC, et al. A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy[J]. Clin Mol Hepatol,2016,22(3):396-399.
|
[13] |
马晓瑞, 李红霞, 马利. 348例药物性肝损害的临床分析[J]. 西安交通大学学报(医学版),2021,42(6):909-914.
|
[14] |
程丽. 药物性肝损害临床分析[D]. 山东大学,2016.
|
[15] |
van Mil SW, van der Woerd WL, van der Brugge G, et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11[J]. Gastroenterology,2004,127(2):379-384.
|
[16] |
Klomp LW, Vargas JC, van Mil SW, et al. Characterization of mutations in ATP8B1 associated with hereditary cholestasis[J]. Hepatology,40(1):27-38.
|
[17] |
Wang H, Yang L, Wang J. Etiology of neonatal cholestasis after emerging molecular diagnostics[J]. Transl Pediatr,2022,11(3):359- 367.
|
[18] |
Zissimopoulos A, Cassimos D, Deftereos S, et al. Hepatobiliary scan in Alagille syndrome; arteriohepatic dysplasia[J]. Hell J Nucl Med,2009,12(2):158-60.
|
[19] |
王璐, 韩英. 原发性硬化性胆管炎诊治进展[J/CD]. 中国医学前沿杂志(电子版),2020,12(2):7-12.
|
[20] |
宋佳, 尹凤荣, 王冬, 等. 伴肝内胆汁淤积的多系统朗格汉斯细胞组织细胞增生症[J]. 中华消化杂志,2020,40(10):704-708.
|
[21] |
王策, 于宪一. 320例川崎病患儿临床特点及冠状动脉损伤的高危因素分析[J]. 中国小儿急救医学,2018,25(12):939-942, 947.
|
[22] |
谢中国, 刘洋, 吴婷婷. 川崎病并发毛细血管渗漏综合征及肝内胆汁淤积一例[J]. 中华儿科杂志,2016,54(2):156-157.
|
[23] |
Pratap K, Gardner LS, Gillis D, et al. Hepatic predominant presentation of Kawasaki disease in adolescence case report and review of literature[J]. BMC Gastroenterol,2020,20(1):352.
|
[24] |
Cha S, Yoon M, Ahn Y, et al. Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease[J]. J Korean Med Sci. 2008;23(4):718-722.
|
[25] |
Yi DY, Kim JY, Choi EY, et al. Hepatobiliary risk factors for clinical outcome of Kawasaki disease in children[J]. BMC Pediatr,2014,14:51.
|
[26] |
杜曾庆, 马越明, 王美芬, 等. 川崎病并发无菌性脑膜炎53例临床分析[J]. 中国小儿急救医学,2012,19(3):294-296.
|
[27] |
中华医学会儿科学分会心血管学组, 中华医学会儿科学分会风湿学组, 中华医学会儿科学分会免疫学组, 中华儿科杂志编辑委员会. 川崎病诊断和急性期治疗专家共识[J]. 中华儿科杂志,2022,60(1):6-13.
|
[28] |
王程浩, 刘芳. 川崎病所致冠状动脉病变的病理改变及结局[J]. 中华实用儿科临床杂志,2021,36(22):1757-1760.
|